Private Equity

Cosmos Health's subsidiary will manufacture the advanced generic pain reliever PathMuscle, securing a major contract and enhancing its European footprint.

Limbach Holdings appoints M&A and operations expert Terry Dugan to its board, a strategic move aimed at accelerating growth in mission-critical markets.

The acclaimed '1/6' graphic novel series releases its finale, a resistance-driven story that eerily anticipated authoritarian moves in a post-Jan. 6 world.

A new joint venture between Corewell Health and Quest Diagnostics aims to reshape lab services across Michigan with a new high-tech facility and new efficiencies.

As the private equity market rebounds, Evercore hires a seasoned banker to strengthen its financial sponsors group, signaling a major strategic play.

LENZ Therapeutics partners with Lunatus to launch its breakthrough VIZZ™ presbyopia eye drops in the Middle East, targeting a vast, unmet medical need.

AMC Robotics establishes a new manufacturing hub in Ho Chi Minh City, a strategic move to scale its Kyro robot and join the global tech shift to Vietnam.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

AE Industrial acquires L3Harris's propulsion unit, reviving the iconic Rocketdyne name to modernize legacy engines and pioneer nuclear power for deep space.

The world’s largest private oil producer expands its stake in the Vaca Muerta, betting its US shale expertise can unlock a world-class energy resource.

Lakestreet Capital, Palace Capital's largest shareholder, demands the removal of Chairman Steven Owen, citing excessive pay and poor governance.

Fresh off a massive 240% revenue surge, Nutex Health prepares to showcase its micro-hospital model and physician-led strategy to top global investors.

Abingworth elevates Bali Muralidhar and hires Travis Wilson, signaling a major push into clinical co-development and buyouts under Carlyle's wing.

Health Canada has approved JERAYGO, the first new hypertension drug class in 30 years, offering a lifeline to patients with hard-to-treat high blood pressure.

E-commerce logistics firm Globavend Holdings raised $1.4M in a direct offering, but its stock tumbled. A look at the deal, the market, and what's next.

CEO Eric Hambly will face investors at a key conference, balancing oil production strategy with the rising tide of clean technology and decarbonization.

Northann Corp. stock soars on a major retail partnership, but can its innovative 3D printing tech overcome deep financial woes and a delisting threat?

A strategic partnership between Arkview Capital and BBK Capital secures NEOTech, a key electronics supplier, aiming to bolster US defense and tech manufacturing.

As DSOs and consolidation reshape Canadian dentistry, Mint Ops launches a non-broker advisory service to guide owners on growth and buy/sell decisions.